SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015755
Filing Date
2022-08-09
Accepted
2022-08-09 07:31:25
Documents
88
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q beam-20220630.htm   iXBRL 10-Q 3273352
2 EX-31.1 beam-ex31_1.htm EX-31.1 22058
3 EX-31.2 beam-ex31_2.htm EX-31.2 22214
4 EX-32.1 beam-ex32_1.htm EX-32.1 12906
5 EX-32.2 beam-ex32_2.htm EX-32.2 12935
  Complete submission text file 0000950170-22-015755.txt   12755222

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT beam-20220630.xsd EX-101.SCH 74363
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT beam-20220630_def.xml EX-101.DEF 303884
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT beam-20220630_lab.xml EX-101.LAB 551920
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT beam-20220630_pre.xml EX-101.PRE 478206
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT beam-20220630_cal.xml EX-101.CAL 64381
82 EXTRACTED XBRL INSTANCE DOCUMENT beam-20220630_htm.xml XML 2834502
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 221146415
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences